These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2968272)

  • 21. The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
    Plantjé JF; Hansen HA; Daus FJ; Stoof JC
    Eur J Pharmacol; 1984 Oct; 105(1-2):73-83. PubMed ID: 6208045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.
    Arnt J; Hyttel J; Bach-Lauritsen T
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):319-24. PubMed ID: 2879412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
    Hicks PE; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1985 Mar; 109(3):349-54. PubMed ID: 3157586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P; Karlsson T; Ahlenius S
    Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor.
    Cheetham SC; Heal DJ
    Br J Pharmacol; 1993 Dec; 110(4):1621-9. PubMed ID: 8306109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
    Hoyer D; Karpf A
    Eur J Pharmacol; 1988 May; 150(1-2):181-4. PubMed ID: 3402537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
    Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
    Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats.
    Wanibuchi F; Usuda S
    Psychopharmacology (Berl); 1990; 102(3):339-42. PubMed ID: 1979179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of 5-HT1-like receptors in the increase in intragastric pressure induced by 5-hydroxytryptamine in the rat.
    Dhasmana KM; Villalón CM; Zhu YN; Tadipatri S; Saxena PR
    Eur J Pharmacol; 1992 Mar; 213(2):293-9. PubMed ID: 1521563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The St 587-induced flexor reflex in pithed rats: a model to evaluate central alpha 1-receptor blocking properties.
    Skarsfeldt T; Hyttel J
    Eur J Pharmacol; 1986 Jun; 125(3):333-40. PubMed ID: 2874039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
    Ohlstein EH; Berkowitz BA
    Eur J Pharmacol; 1985 Jan; 108(2):205-8. PubMed ID: 3884345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
    Itoh Y; Beaulieu M; Kebabian JW
    Eur J Pharmacol; 1984 Apr; 100(1):119-22. PubMed ID: 6144550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.